Gene structure, promoter characterization, and basis for alternative mRNA splicing of the human CD58 gene

Journal of Immunology

Volumn 160, Issue 6, 1998, Pages 2862-2871

  Wallich, Reinhard ^a   Brenner, Christiane ^a   Brand, Yvonne ^a   Roux, Matthias ^a   Reister, Manuel ^a   Meuer, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CHROMOSOME 13Q; DNA SEQUENCE; GENE LOCATION; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; SILENCER GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANTIGENS, CD58; BASE SEQUENCE; CELLS, CULTURED; DNA, COMPLEMENTARY; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032521037     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Bierer, B. E., A. Peterson, J. Barbosa, B. Seed, and S. J. Burakoff. 1988. Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation. Proc. Natl. Acad. Sci. USA 85:1194.
2. Moingeon, P., H.-C. Chang, B. P. Wallner, C. Stebbins, A. Z. Frey, and E. L. Reinherz. 1989. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature 339:312.
3. Koyasu, S., T. Lawton, D. Novick, M. A. Recny, R. F. Siliciano, B. P. Wallner, and E. L. Reinherz. 1990. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. Proc. Natl. Acad. Sci. USA 87:2603.
4. Hünig, T., G. Tiefenthaler, K.-H. Meyer zum Büschenfelde, and S. C. Meuer. 1987. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand. Nature 326:298.
5. Meuer, S. C., R. E. Hussey, M. Fabbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. C. Hodgdon, J. P. Protentis, S. F. Schlossman, and E. L. Reinherz. 1984. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 36:897.
6. Dengler, T. J., J. C. Hoffmann, P. Knolle, M. Albert-Wolf, M. Roux, R. Wallich, and S. C. Meuer. 1992. Structural and functional epitopes of the human adhesion receptor CD58 (LFA-3). Eur. J. Immunol. 22:2809.
7. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425.
8. Dustin, M. L., P. Selvaraj, R. J. Mattaliano, and T. A. Springer. 1987. Anchoring mechanism for LFA-3 cell adhesion glycoprotein at membrane surface. Nature 329:846.
9. Wallner, B. P., A. Z. Frey, R. Tizard, R. J. Mattaliano, C. Hession, M. E. Sanders, M. L. Dustin, and T. A. Springer. 1987. Primary structure of lymphocyte function-associated antigen 3 (LFA-3). J. Exp. Med. 166:923.
10. Seed, B. 1987. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature 329:840.
11. Volpes, R., J. J. Van den Oord, and V. J. Desmet. 1990. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 12:59.
12. Autschbach, F., S. C. Meuer, U. Moebius, M. Manns, G. Hess, K.-H. Meyer zum Büschenfelde, W. Thoenes, and H. P. Dienes. 1991. Hepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis. Hepatology 14:223.
13. Nouri, A. M. E., M. E. F. Smith, D. Crosby, and R. T. D. Oliver. 1990. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma. Br. J. Cancer 62:603.
14. Rabinowitz, R., A. Polliack, R. Leizerowitz, Y. Keren-Zur, and M. Schlesinger. 1991. Expression of CD11a (LFA-1) on B-chronic lymphocytic leukemia and lymphoma cells: correlation with cell surface immunoglobulin intensity and CD58 (LFA-3) expression. Leuk. Lymphoma 5(Suppl.):59.
15. Busson, P., Q. Zhang, J.-M. Guillon, C. D. Gregory, L. S. Young, B. Clausse, M. Lipinski, A. B. Rickinson, and T. Tursz. 1992. Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cells. Int. J. Cancer 50:863.
16. Archimbaud, E., X. Thomas, L. Campos, J. -P. Magaud, J.-F. Doré, and D. Fiere. 1992. Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis. Leukemia 6:265.
17. Scheibenbogen, C., U. Keilholz, S. Meuer, T. Dengler, W. Tilgen, and W. Hunstein. 1993. Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines. Int. J. Cancer 54:494.
18. Tanaka, Y., K. Fukudome, M. Hayashi, S. Takagi, and O. Yoshie. 1995. Induction of ICAM-1 and LFA-3 by Tax1 of human T-cell leukemia virus type 1 and mechanism of down-regulation of ICAM-1 or LFA-1 in adult-T-cell-leukemia cell lines. Int. J. Cancer 60:554.
19. Mayer, B., C. Lorenz, R. Babic, K. W. Jauch, F. W. Schildberg, I. Funke, and J. P. Johnson. 1995. Expression of leukocyte cell adhesion molecules on gastric carcinomas: possible involvement of LFA-3 expression in the development of distant metastases. Int. J. Cancer 64:415.
20. Schirren, C. A., H. Völpel, J. C. Hoffmann, S. W. Henning, L. Qiao, F. Autschbach, T. J. Dengler, H. Döhner, and S. C. Meuer. 1993. Biological response modifiers render tumor cells susceptible to autologous effector mechanisms by influencing adhesion receptors. Leuk. Lymphoma 10:25.
21. Hoffmann, J. C., T. J. Dengler, P. A. Knolle, M. Albert-Wolf, M. Roux, R. Wallich, and S. C. Meuer. 1993. A soluble form of the adhesion receptor CD58 (LFA-3) is present in human body fluids. Eur. J. Immunol. 23:3003.
22. Hoffmann, J. C., B. Bayer, and H. Zeidler. 1996. Characterization of a soluble form of CD58 in synovial fluid of patients with rheumatoid arthritis (RA). Clin. Exp. Immunol. 104:460.
23. Albert-Wolf, M., S. C. Meuer, and R. Wallich. 1991. Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathway. Int. Immunol. 3:1335.
24. Cybulsky, M. I., J. W. U. Fries, A. J. Williams, P. Sultan, R. Eddy, M. Byers, T. Shows, M. A. Gimbrone, Jr., and T. Collins. 1991. Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene. Proc. Natl. Acad. Sci. USA 88:7859.
25. Arulanandam, A. R. N., J. M. Withka, D. F. Wyss, G. Wagner, A. Kister, P. Pallai, M. A. Recny, and E. L. Reinherz. 1993. The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C face of the human CD2 adhesion domain. Proc. Natl. Acad. Sci. USA 90:11613.
26. Van der Merwe, P. A., A. N. Barclay, D. W. Mason, E. A. Davies, B. P. Morgan, M. Tone, A. K. C. Krishnam, C. Ianelli, and S. J. Davis. 1994. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 33:10149.
27. Arulanandam, A. R. N., A. Kister, M. J. McGregor, D. F. Wyss, G. Wagner, and E. L. Reinherz. 1994. Interaction between human CD2 and CD58 involves the major β sheet surface of each of their respective adhesion domains. J. Exp. Med. 180:1861.
28. Poustka, A., H.-R. Rackwitz, A.-M. Frischauf, B. Hohn, and H. Lehrach. 1984. Selective isolation of cosmid clones by homologous recombination in Escherichia coli. Proc. Natl. Acad. Sci. USA 81:4129.
29. Lehrach, H. 1990. Genetic and physical mapping. In Genome Analysis, Vol. 1. K. E. Davies and S. M. Tilghman, eds. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, p. 39.
30. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463.
31. Wallich, R., S. E. Moter, M. M. Simon, K. Ebnet, A. Heiberger, and M. D. Kramer. 1990. The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene. Infect. Immun. 58:1711.
32. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Schraven, B., D. Schoenhaut, E. Bruyns, G. Koretzky, C. Eckerskorn, R. Wallich, H. Kirchgessner, P. Sakorafas, B. Labkovsky, S. Ratnofsky, and S. Meuer. 1994. LPAP, a novel 32-kDa phosphoprotein that interacts with CD45 in human lymphocytes. J. Biol. Chem. 269:29102.
34. Williams, A. F., and A. N. Barclay. 1988. The immunoglobulin superfamily-domains for cell surface recognition. Annu. Rev. Immunol. 6:381.
35. Lichter, P., C.-J. C. Tang, K. Call, G. Hermanson, G. A. Evans, D. Housman, and D. C. Ward. 1990. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247:64.
36. Low, M. G. 1987. Biochemistry of the glycosyl-phosphatidylinositol membrane protein anchors. Biochem. J. 244:1.
37. Breathnach, R., and P. Chambon. 1981. Organization and expression of eukaryotic split genes coding for proteins. Annu. Rev. Biochem. 50:349.
38. Mount, S. M. 1982. A catalogue of splice junction sequences. Nucleic Acids Res. 10:459.
39. Pugh, B. F., and R. Tjian. 1990. Mechanism of transcriptional activation by Sp1: evidence for coactivators. Cell 61:1187.
40. Klemsz, M. J., S. R. McKercher, A. Celada, C. Van Beveren, and R. A. Maki. 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113.
41. Ho, I. C., P. Vorhees, N. Marin, B. K. Oakley, S. F. Tsai, S. H. Orkin, and J. M. Leiden. 1991. Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene. EMBO J. 10:1187.
42. Ko, L. J., M. Yamamoto, M. W. Leonard, K. M. George, P. Ting, and J. D. Engel. 1991. Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol. Cell. Biol. 11:2778.
43. Williams, T., and R. Tjian. 1991. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev. 5:670.
44. Parslow, T. G., D. L. Blair, W. J. Murphy, and D. K. Granner. 1984. Structure of the 5′ ends of immunoglobulin genes: a novel conserved sequence. Proc. Natl. Acad. Sci. USA 81:2650.
45. Falkner, F. G., and H. G. Zachau. 1984. Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements. Nature 310:71.
46. Birnstiel, M. L., M. Busslinger, and K. Strub. 1985. Transcription termination and 3′ processing: the end is in site. Cell 41:349.
47. Stade, B. G., G. Messer, G. Riethmüller, and J. P. Johnson. 1990. Structural characteristics of the 5′ region of the human ICAM-1 gene. Immunobiology 182:79.
48. Stolpe, A. van de, E. Caldenhoven, B. G. Stade, L. Koenderman, J. A. M. Raaijmakers, J. P. Johnson, and P. T. van der Saag. 1994. 12-o-Tetradecanoylphorbol-13-acetate- and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. J. Biol. Chem. 269:6185.
49. Diamond, D. J., L. K. Clayton, P. H. Sayre, and E. L. Reinherz. 1988. Exonintron organization and sequence comparison of human and murine T11 (CD2) genes. Proc. Natl. Acad. Sci. USA 85:1615.
50. Lang, G., D. Wotton, M. J. Owen, W. A. Sewell, M. H. Brown, D. Y. Mason, M. J. Crumpton, and D. Kioussis. 1988. The structure of the human CD2 gene and its expression in transgenic mice. EMBO J. 7:1675.
51. Watson, M. L., S. F. Kingsmore, G. I. Johnston, M. H. Siegelman, M. M. Le Beau, R. S. Lemons, N. S. Bora, T. A. Howard, I. L. Weissman, R. P. McEver, and M. F. Seldin. 1990. Genomic organization of the selectin family of leukocyte adhesion molecules on human and mouse chromosome 1. J. Exp. Med. 172:263.
52. Ushiyama, S., T. M. Laue, K. L. Moore, H. P. Erickson, and R. P. McEver. 1993. Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin. J. Biol. Chem. 268:15229.
53. Yamamoto, M., L. J. Ko, M. W. Leonard, H. Beug, S. H. Orkin, and J. D. Engel. 1990. Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev. 4:1650.
54. Evans, T., M. Reitman, and G. Felsenfeld. 1988. An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc. Natl. Acad. Sci. USA 85:5976.
55. Dynan, W. S. 1989. Modularity in promoters and enhancers. Cell 58:1.
56. Mitchell, P. J., and R. Tjian. 1989. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245:371.
57. Imai, T., Y. Tanaka, K. Fukudome, S. Takagi, K. Araki, and O. Yoshie. 1993. Enhanced expression of LFA-3 on human T-cell lines and leukemic cells carrying human T-cell-leukemia virus type 1. Int. J. Cancer 55:811.
58. Craigen, J. L., and J. E. Grundy. 1996. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment. Transplantation 62:1102.
59. Kvale, D., P. Krajci, and P. Brandtzaeg. 1992. Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines. Scand. J. Immunol. 35:669.
60. Rousset, F., M. Billaud, D. Blanchard, C. Figdor, G. M. Lenoir, H. Spits, and J. E. De Vries. 1989. IL-4 induces LFA-1 and LFA-3 expression on Burkett's lymphoma cell lines. J. Immunol. 143:1490.
61. Greaves, D. R., F. D. Wilson, G. Lang, and D. Kioussis. 1989. Human CD2 3′-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice. Cell 56:979.
62. Outram, S. V., and M. J. Owen. 1994. The helix-loop-helix containing transcription factor USF activates the promoter of the CD2 gene. J. Biol. Chem. 269:26525.